Drugmaker Sues Credit Suisse Over Risky Investments

Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud.

  • 20 Oct 2009
Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud. Filed in U.S. District Court for the Southern District of New York, the lawsuit alleges that the bank fraudulently invested more than $545 million of Roche's cash in “collateralized ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 3,319 10 12.84
2 Citi 2,562 6 9.92
3 Goldman Sachs 2,150 3 8.32
4 Credit Suisse 1,822 6 7.05
5 Societe Generale 1,814 4 7.02

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 22 May 2017
1 Citi 41,255.30 117 12.99%
2 Bank of America Merrill Lynch 37,631.92 109 11.85%
3 Wells Fargo Securities 32,082.26 89 10.11%
4 JPMorgan 20,969.41 64 6.60%
5 Credit Suisse 16,754.47 44 5.28%